Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMC

Coping with artifact in the analysis of flow cytometric data

Donnenberg VS., Donnenberg AD.

Laboratory Study, published in Methods (2015) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Methods (2015)
Reported sample size
—
Source database
Europe PMC
PMID
25823849
PMCID
PMC12871547
DOI
10.1016/j.ymeth.2015.03.012
Citations
19

Abstract (original English)

This article highlights several sources of artifact that interfere with optimal analysis of flow cytometric data. Such problems are compounded when flow cytometry is performed on mechanically and enzymatically disaggregated solid tissues or on cultured cells, where subcellular debris, apoptotic or necrotic cells, and highly autofluorescent cells may comprise a substantial proportion of acquired events. We provide real-world examples of tissues that pose specific analytical challenges (bone marrow, breast cancer, lung cancer and adipose tissue) and suggest approaches to improve data analysis. These include the use of a sequential or hierarchical gating process, which envisions analysis as consisting of three parts: (1) removal of artifact; (2) defining classifying populations; and (3) measuring outcomes on the classifying populations. Tools for removal of artifact include use of the time parameter to detect and remove fluidic perturbations, use of doublet discrimination to avoid analysis of cell clusters, measurement of DNA content to remove subcellular debris and late apoptotic cells, Boolean gating to recognize and remove auto-fluorescent events, and the use of a dump gate (markers known to be negative on the population of interest, but expressed on interfering cells). Implementation of these strategies, as appropriate, extends the usefulness of flow cytometry to a wider range

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueBone Marrow CellsHumansBreast NeoplasmsLung NeoplasmsArtifactsFlow CytometryFemale

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.